Multidrug Resistant Tuberculosis: Postponed Treatment Outcomes
https://doi.org/10.58838/2075-1230-2026-104-2-33-37
Abstract
The objective: to evaluate postponed treatment outcomes in the patients with multidrug resistant tuberculosis (MDR TB) detected during preventive screening and by self-referral to a medical unit.
Subjects and Methods. Data from in-patient records of 147 patients were retrospectively analyzed. All those patients had MDR TB with a positive result of sputum tests and underwent treatment in the Grondo Regional Clinical Center of Phthisiology.
Results. 103/147 (70.1%) cases of pulmonary tuberculosis were detected by screening, while 44/147 (29.9%) were detected by self-referral, p<0.001. It was possible to trace treatment outcomes in 114 patients only. Sputum conversion was achieved in the patients detected by screening within 6 months (inclusive) which was statistically significantly more frequently than among patients identified during self-referral (61/82 (74.4%) versus 15/32 (46.9%), p≤0.05). Over 18 months, successful treatment outcomes were achieved statistically significantly more often in patients detected by screening (26/82 (31.7%), 95% CI 22.6-42.4) versus self-referral (4/32 (12.5%), 95% CI 5.0-28.1), p=0.046. Of 114 patients, a favorable treatment outcome was achieved in 86 (75.4%) 95% CI (66.8-82.4) patients, regardless of the duration of treatment and the way of tuberculosis detection: 65 patients detected by screening and 21 patients detected by self-referral.
About the Author
T. Yu. Liashchuk
Grodno State Medical University
Belarus
Belarus
Tatiana Yu. Liashchuk - Candidate of Medical Sciences, Senior Teacher of X-Ray Diagnostic Department
80 Gorkogo St.,Grodno, 230009
Phone: + 375 (152) 44-36-52
References
1. Vasilyeva I.A., Belilovsky E.M., Borisov S.E., Sterlikov S.A. Multiple drug resistant tuberculosis in the world and Russian Federation. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 11, pp. 5-17. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-11-5-17
2. Nechaeva O.B. TB situation in Russia. Tuberculosis and Lung Diseases, 2018, vol. 95, no. 8, pp. 15-24. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-8-15-24
3. Pyanzova T.V., Sterlikov S.A., Zimina V.N., Sibil K.V., Kudrina V.G., Karabchukov K.B., Vasilyeva I.A. The impact of active case-finding of pulmonary tuberculosis on the epidemiological risk of patients and their treatment outcomes in a big industrial region (Kuzbass). Tuberculosis and Lung Diseases, 2025, vol. 103, no. 4, pp. 44-51. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-4-44-51
4. Skryagina E.M., Gurevich G.L., Astrovko A.P., Kalechits O.M., Zalutskaya O.M., Skryagin A.E. Effective ways of solving the problem of multudrug-resistant tuberculosis in the Republic of Belarus. Tuberculosis and Lung Diseases, 2014, vol. 91, no. 3, pp. 18-24. (In Russ.)
5. Sterlikov S.A., Galkin V.B., Maliev B.M., Shirokova A.A., Khorotetto V.A., Mayzhegisheva A.S. Impact of active case finding on treatment outcomes in adult pulmonary tuberculosis patients. Tuberculosis and Lung Diseases, 2021, vol. 99, no. 7, pp. 33-40. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-7-33-40
6. Alene K.A., Clements ACA., McBryde E.S, Jaramillo E., Lonnroth K., Shaweno D., Viney K. Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis. BMJ Open, 2018, vol. 8, no. 2, pp. e019593. https://doi.org/10.1136/bmjopen-2017-019593
7. Bastos M.L., Lan Z. Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur. Respir. J., 2017, vol. 49, no. 3, pp. 1600803. https://doi.org/10.1183/13993003.00803-2016
8. Dean A.S., Cox H., Zignol M. Epidemiology of drug-resistant tuberculosis: review. Adv. Exp. Med. Biol., 2017, no. 1019, pp. 209-220. https://doi.org/10.1007/978-3-319-64371-7_11
9. Global Tuberculosis Report for 2024. World Health Organization. Geneva, WHO, 2024. Available: www.who.int/teams/global-programme-on-tubercu losis-and-lung-health/tb-reports/global-tuberculosis-report-2024 Accessed September 28, 2025
10. Iacobino A., Fattorini L., Giannoni F. Drug-resistant tuberculosis 2020: where we stand. Appl. Sci., 2020, vol. 10, no. 6, pp. 2153. https://doi.org/10.3390/app10062153
11. Kang Y., Jo E.J., Eom J.S., Kim M.H., Lee K., Kim K.U., Park H.K., Lee M.K., Mok J. Treatment outcomes of patients with multidrug-resistant tuberculosis: comparison of pre- and post-public-private mix periods. Tuberc. Respir. Dis. (Seoul), 2021, vol. 84, no. 1, pp. 74-83. https://doi.org/10.4046/trd.2020.0093
12. Kontsevaya I., Nikolayevskyy V., Kovalyov A., Ignatyeva O., Sadykhova A., Simak T. et al. Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes. Infect. Genet. Evol., 2017, no. 48, pp. 76-82. https://doi.org/10.1016/j.meegid.2016.12.016
13. Korablioviene J., Mauricas M., Caplinskas S., Zagrebneviene G., Korabliov P. The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU). J. Prev. Med. Hyg., 2018, vol. 59, no. 4, pp. 328-335. https://doi.org/10.15167/2421-4248/jpmh2018.59.4.926
14. Lange C., Chesov D., Heyckendorf J., Leung C.C., Udwadia Z., Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology, 2018, vol. 23, no. 7, pp. 656-673. https://doi.org/10.1111/resp.13304
15. Lei X., Liu Q., Escobar E., Philogene J., Zhu H., Wang Y., Tang S. Public-private mix for tuberculosis care and control: a systematic review. Int. J. Infect. Dis., 2015, no. 34, pp. 20-32. https://doi.org/10.1016/j.ijid.2015.02.015
16. Salari N., Kanjoori A. H., Hosseinian-Far A. et al. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect. Dis. Poverty, 2023, vol. 12, no. 1, pp. 57. https://doi.org/10.1186/s40249-023-01107-x
17. Singla R., Mallick M., Mrigpuri P., Singla N., Gupta A. Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment. Lung India, 2018, vol. 35, no. 1, pp. 4-8. https://doi.org/10.4103/lungindia.lungindia_269_16
18. van Kampen S.C., Wanner A., Edwards M., Harries A.D., Kirenga B.J., Chakaya J., Jones R. International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review. BMJ Glob. Health, 2018, vol. 3, no. 4, pp. e000745. https://doi.org/10.1136/bmjgh-2018-000745
Review
For citations:
Liashchuk T.Yu. Multidrug Resistant Tuberculosis: Postponed Treatment Outcomes. Tuberculosis and Lung Diseases. 2026;104(2):33-37. (In Russ.) https://doi.org/10.58838/2075-1230-2026-104-2-33-37
Views:
152
JATS XML
Email this article 